Erik Nordwald

Associate Director, Process Technology and Innovation at KBI Biopharma

Speaker

Dr. Nordwald received his PhD in protein engineering from the University of Colorado, Boulder. After obtaining his PhD, he worked for a startup company for about three years developing the full manufacturing process for an enzyme intended to mitigate kidney stone risk. The manufacturing process was scaled to 5m3 fermentation scale and successfully launched commercially before he transitioned to working for KBI Biopharma. He has been with KBI for nearly 6 years as an upstream process development scientist, leading its microbial cell line development group, and now leading the company's microbial process technology and innovation group. Dr. Nordwald has a passion to realize the dream of fast, inexpensive drug development.